News & Updates
Showing Endocrinology articles
Showing
Show Multimedia Only

Semaglutide lowers kidney fat, improves glomerular haemodynamic in T2D patients with CKD
25 Nov 2025
byStephen Padilla
Treatment with semaglutide helps reduce kidney fat and enhance glomerular haemodynamic in adult patients with type 2 diabetes (T2D) and chronic kidney disease (CKD), as shown in the REMODEL trial.
Semaglutide lowers kidney fat, improves glomerular haemodynamic in T2D patients with CKD
25 Nov 2025
Managing obesity-related cardiovascular risk in primary care
08 Nov 2025
Obesity and overweight are now among the most pervasive health challenges worldwide, contributing substantially to the burden of cardiovascular disease (CVD). In Singapore, the 2022 National Population Health Survey reported that one in nine adults is obese, while nearly a third are overweight—a trend that continues to climb. [https://isomer-user-content.by.gov.sg/3/28c3b8f9-9216-46be-8fc9-b614098666a9/nphs-2022-survey-report_final.pdf]







